Patents Assigned to Histogenics Corporation
-
Publication number: 20220265900Abstract: The invention relates to implantable systems for repairing and restoring cartilage. The invention provides methods and products for cartilage repair that use universal chondrocytes. A universal cell line includes cells such as universal chondrocytes that are not immunogenic or allergenic and can be grown in products suitable for use in a number of different people. Use of the universal chondrocytes allows for new processes and products. Where prior art autologous neocartilage constructs required many small reactors (e.g., at least one culture dish per patient to grow one 34 mm disc per patient), using a universal cell line allows, for example, one large batch of cartilage or neocartilage to be made under uniform conditions.Type: ApplicationFiled: February 10, 2022Publication date: August 25, 2022Applicant: Histogenics CorporationInventor: Stephen Richard KENNEDY
-
Publication number: 20210246418Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.Type: ApplicationFiled: January 22, 2021Publication date: August 12, 2021Applicant: Histogenics CorporationInventors: Robert Lane Smith, Laurence J.B. Tarrant, Akihiko Kusanagi, Hans P.I. Claesson
-
Publication number: 20210161672Abstract: An injury or defect in articular cartilage is treated with a matrix implant that is applied above a barrier composition. The polymer-containing barrier composition is applied to the bottom of a cartilage lesion. The barrier composition can block migration of cells, blood, or other material from subchondral bone into the cartilage lesion.Type: ApplicationFiled: June 10, 2019Publication date: June 3, 2021Applicant: HISTOGENICS CORPORATIONInventor: James KROM
-
Publication number: 20210059805Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.Type: ApplicationFiled: November 16, 2020Publication date: March 4, 2021Applicant: HISTOGENICS CORPORATIONInventors: Sonya Shortkroff, Laurence J.B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P.I. Claesson
-
Patent number: 10900017Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.Type: GrantFiled: December 6, 2019Date of Patent: January 26, 2021Assignee: HISTOGENICS CORPORATIONInventors: Robert Lane Smith, Laurence J. B. Tarrant, Akihiko Kusanagi, Hans P. I. Claesson
-
Patent number: 10842610Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.Type: GrantFiled: May 11, 2018Date of Patent: November 24, 2020Assignee: Histogenics CorporationInventors: Sonya Shortkroff, Laurence J. B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P. I. Claesson
-
Publication number: 20200224155Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.Type: ApplicationFiled: December 6, 2019Publication date: July 16, 2020Applicant: HISTOGENICS CORPORATIONInventors: Robert Lane Smith, Laurence J.B. Tarrant, Akihiko Kusanagi, Hans P.I. Claesson
-
Publication number: 20200093962Abstract: Neo-cartilage constructs suitable for implantation into a joint cartilage lesion in situ and a method for repair and restoration of function of injured, traumatized, aged or diseased cartilage. The construct comprises at least chondrocytes incorporated into a support matrix processed according to the algorithm comprising variable hydrostatic or atmospheric pressure or non-pressure conditions, variable rate of perfusion, variable medium composition, variable temperature, variable cell density and variable time to which the chondrocytes are subjected.Type: ApplicationFiled: July 30, 2019Publication date: March 26, 2020Applicants: HISTOGENICS CORPORATION, TAKAGI INDUSTRIAL CO. LTD.Inventors: Shuichi Mizuno, Akihiko Kusanagi, Laurence J.B. Tarrant, Toshimasa Tokuno, Robert Lane Smith
-
Publication number: 20200086005Abstract: The invention relates to implantable systems for repairing and restoring cartilage. The invention provides methods and products for cartilage repair that use universal chondrocytes. A universal cell line includes cells such as universal chondrocytes that are not immunogenic or allergenic and can be grown in products suitable for use in a number of different people. Use of the universal chondrocytes allows for new processes and products. Where prior art autologous neocartilage constructs required many small reactors (e.g., at least one culture dish per patient to grow one 34 mm disc per patient), using a universal cell line allows, for example, one large batch of cartilage or neocartilage to be made under uniform conditions.Type: ApplicationFiled: April 25, 2019Publication date: March 19, 2020Applicant: HISTOGENICS CORPORATIONInventor: Stephen Richard Kennedy
-
Publication number: 20190321451Abstract: The invention generally relates to systems (i.e. constructs) for repairing cartilage and methods for preparing the same that introduce a bioactive agent into a culture medium, suspension, scaffold, solution incorporated into the pores of the scaffold, or combinations thereof. The introduction of a bioactive agent promotes production of neo-cartilage (i.e. immature hyaline cartilage) in the system, both ex-vivo and in-vivo.Type: ApplicationFiled: July 5, 2019Publication date: October 24, 2019Applicant: Histogenics CorporationInventors: Laurence J.B. Tarrant, Sonya Shortkroff, Shuichi Mizuno, Akihiko Kusanagi, Toshimasa Tokuno, Robert Lane Smith
-
Publication number: 20190010439Abstract: The invention generally relates to containers for cell and tissue culturing with multiple compartments in fluid communication with each other to provide a common culture environment in each of the compartments while maintaining physical separation of cells and tissue therein. The invention further relates to culture containers providing a sterile culture environment with detachably coupleable lids and open access to each compartment within a container.Type: ApplicationFiled: September 14, 2018Publication date: January 10, 2019Applicant: Histogenics CorporationInventor: Eric Blahut
-
Patent number: 10077420Abstract: The invention generally relates to containers for cell and tissue culturing with multiple compartments in fluid communication with each other to provide a common culture environment in each of the compartments while maintaining physical separation of cells and tissue therein. The invention further relates to culture containers providing a sterile culture environment with detachably coupleable lids and open access to each compartment within a container.Type: GrantFiled: December 2, 2014Date of Patent: September 18, 2018Assignee: Histogenics CorporationInventor: Eric Blahut
-
Publication number: 20180256309Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand-alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand-alone secondary scaffold implant or unit for treatment of tissue defects.Type: ApplicationFiled: May 11, 2018Publication date: September 13, 2018Applicant: Histogenics CorporationInventors: Sonya Shortkroff, Laurence J.B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P.I. Claesson
-
Patent number: 9993326Abstract: A method for use of a double-structured tissue implant or a secondary scaffold stand alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand alone secondary scaffold implant or unit for treatment of tissue defects.Type: GrantFiled: August 25, 2015Date of Patent: June 12, 2018Assignee: Histogenics CorporationInventors: Sonya Shortkroff, Laurence J. B. Tarrant, Eric J. Roos, Robert Lane Smith, Hans P. I. Claesson
-
Publication number: 20170312391Abstract: A double-structured tissue implant and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A stand alone secondary scaffold implant or unit. A process for preparation of the double-structured implant or the stand alone secondary scaffold comprising lyophilization and dehydrothermal treatment.Type: ApplicationFiled: June 23, 2017Publication date: November 2, 2017Applicant: Histogenics CorporationInventors: Hans Peter Ingemar Claesson, Laurence J.B. Tarrant, Robert Lane Smith, Sonya Shortkroff
-
Patent number: 9701940Abstract: A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.Type: GrantFiled: December 19, 2014Date of Patent: July 11, 2017Assignee: Histogenics CorporationInventors: R. Lane Smith, Laurence J. B. Tarrant, Akihiko Kusanagi, Hans P. I. Claesson
-
Patent number: 9687590Abstract: A double-structured tissue implant and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant comprising a primary scaffold comprised of collagen and a secondary scaffold comprising a soluble collagen solution in combination with a surfactant generated and positioned within the primary scaffold. A process for preparation of the double-structured implant or the stand alone secondary scaffold comprising lyophilization and dehydrothermal treatment.Type: GrantFiled: June 21, 2016Date of Patent: June 27, 2017Assignee: Histogenics CorporationInventors: Hans Peter Ingemar Claesson, Laurence J. B. Tarrant, Robert Lane Smith, Sonya Shortkroff
-
Patent number: 9421304Abstract: A double-structured tissue implant (DSTI) and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant for differentiation, growth and transformation of cells, stem cells, mesenchymal stem cells and bone marrow stem cells. DSTI comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold.Type: GrantFiled: August 20, 2008Date of Patent: August 23, 2016Assignee: Histogenics CorporationInventors: Sonya Shortkroff, Joseph Khoury, Laurence J. B. Tarrant, Hans P. I. Claesson, Robert Lane Smith
-
Publication number: 20160206787Abstract: A double-structured tissue implant (DSTI) and a method for preparation and use thereof for implantation into tissue defects. The double-structured tissue implant for differentiation, growth and transformation of cells, stem cells, mesenchymal stem cells and bone marrow stem cells. DSTI comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold.Type: ApplicationFiled: August 20, 2008Publication date: July 21, 2016Applicant: HISTOGENICS CORPORATIONInventors: Sonya Shortkroff, Joseph Khoury, Laurence J.B. Tarrant, Hans P.I. Claesson, Robert Lane Smith
-
Patent number: 9393195Abstract: Neo-cartilage constructs suitable for implantation into a joint cartilage lesion in situ and a method for repair and restoration of function of injured, traumatized, aged or diseased cartilage. The construct comprises at least chondrocytes incorporated into a support matrix processed according to the algorithm comprising variable hydrostatic or atmospheric pressure or non-pressure conditions, variable rate of perfusion, variable medium composition, variable temperature, variable cell density and variable time to which the chondrocytes are subjected.Type: GrantFiled: May 21, 2013Date of Patent: July 19, 2016Assignee: Histogenics CorporationInventors: Shuichi Mizuno, Akihiko Kusanagi, Laurence J. B. Tarrant, Toshimasa Tokuno, Robert Lane Smith